Comparison of therapeutic, immunity and efficacy of topical hydrogen peroxide solution (40% vol) with cryotherapy in seborheic keratosis.

Phase 2

Recruiting

• Conditions: Seborrheic keratosis.; Seborrheic keratosis

• Registration Number: IRCT20220117053747N2
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Age over 18 years
Patient with definite diagnosis of seborrheic keratosis according to diagnostic criteria (Existence of at least one separate lesion in the trunk or limbs with a depth of 0 to 2 mm and length and width of 5 to 15 mm)
Existence of at least 4 lesions of seborrheic keratosis in the individual
Satisfaction to participate in the study

Exclusion Criteria

Presence of the lesion at the site of hair growth (so that the medicine does not reach the lesion well)
Presence of a lesion on the eyelid
Lesions at a distance of 5 mm from the eye

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effectiveness of the treatment will be assessed by the Physician's Lesion Assessment Scale (PLA). The scoring of this scale is 4 numbers (0 = no lesion; 1 = almost no lesion; = Lesions with a depth of more than 1 mm) Patients will be evaluated by this scale at the time of the first visit, 3 weeks later, 6 weeks later and 8 weeks after receiving the treatment. will be. Timepoint: Physician’s lesion assesment scale measurement at the time of the first visit, 3 weeks later, 6 weeks later and 8 weeks after receiving treatment. Method of measurement: Physician’s lesion assesment scale score.